Flow injection spectrophotometric determination of L-ascorbic acid in pharmaceutical formulations with on-line solid-phase reactor containing copper (II) phosphate1Presented at the VII International Conference of Flow Analysis, held in Piracicaba, SP, Brazil, August 25–28, 1997.1

1998 ◽  
Vol 366 (1-3) ◽  
pp. 55-62 ◽  
Author(s):  
Airton Vicente Pereira ◽  
Orlando Fatibello-Filho
2012 ◽  
Vol 48 (2) ◽  
pp. 325-333 ◽  
Author(s):  
Fernando Campanhã Vicentini ◽  
Willian Toito Suarez ◽  
Éder Tadeu Gomes Cavalheiro ◽  
Orlando Fatibello-Filho

A simple flow-injection analysis procedure was developed for determining captopril in pharmaceutical formulations employing a novel solid-phase reactor containing silver thiocyanate immobilized in a castor oil derivative polyurethane resin. The method was based on silver mercaptide formation between the captopril and Ag(I) in the solid-phase reactor. During such a reaction, the SCN- anion was released and reacted with Fe3+, which generated the FeSCN2+ complex that was continuously monitored at 480 nm. The analytical curve was linear in the captopril concentration range from 3.0 × 10-4 mol L-1 to 1.1 × 10-3 mol L-1 with a detection limit of 8.0 × 10-5 mol L-1. Recoveries between 97.5% and 103% and a relative standard deviation of 2% for a solution containing 6.0 × 10-4 mol L-1 captopril (n = 12) were obtained. The sample throughput was 40 h-1 and the results obtained for captopril in pharmaceutical formulations using this procedure and those obtained using a pharmacopoeia procedure were in agreement at a 95% confidence level.


Sign in / Sign up

Export Citation Format

Share Document